Comparison of the Effects of Nintedanib and Pirfenidone on Pulmonary Function Test Parameters and Radiological Findings in Patients with Idiopathic Pulmonary Fibrosis: A Real-Life... by Olcay Aycicek, Serra Keskin, Muhammed Haciosmanoglu, Funda Oztuna, Yilmaz Bulbul, Tevfik Ozlu

Subjects: Get full text

Can Pirfenidone and Nintedanib Be Alternative Treatment Options for Radiation Pneumonitis? by Hikmet COBAN, Mustafa COLAK, Merve YUMRUKUZ ŞENEL, Muzaffer GUNES, Nurhan SARIOGLU, FUAT EREL

Subjects: Get full text

ADDING NINTEDANIB TO IMMUNOSUPPRESSIVE THERAPY IN CONNECTIVE TISSUE RELATED INTERSTITIAL LUNG DISEASES; CASE SERIES BASED ON REAL-LIFE DATA FROM A SINGLE CENTRE by Burak Okyar, Nurhan Atilla, Gözde Yıldırım Çetin, Mehmet Cihan Karacaoğlu, Betül Kızıldağ, Bekir Torun, Esen Saba Öktem, Fatih Yıldız

Subjects: Get full text

Patient characteristics and pharmacologic treatment patterns in antifibrotic-treated patients with fibrosing interstitial lung diseases: real-world results from a claims database by Yasuhiro Kondoh, Tomohiro Ito, Hana Kimura, Haikun Bao, Masataka Kuwana

Subjects: Get full text

Assessment of efficacy, safety, and prognostic/predictive factors of nintedanib/docetaxel in advanced/recurrent non–small cell lung cancer post-immunotherapy and chemotherapy: A Ga... by Natalia Fernández Núñez, Martín Lázaro Quintela, Jorge García González, Francisco Javier Afonso Afonso, María Carmen Areses Manrique, Cristina Azpitarte Raposeiras, Joaquin Mosquera Martinez, Lucia Santomé Couto

Subjects: Get full text

Blockade of the pro‐fibrotic reaction mediated by the miR‐143/‐145 cluster enhances the responses to targeted therapy in melanoma by Serena Diazzi, Alberto Baeri, Julien Fassy, Margaux Lecacheur, Oskar Marin‐Bejar, Christophe A Girard, Lauren Lefevre, Caroline Lacoux, Marie Irondelle, Carine Mounier, Marin Truchi, Marie Couralet, Mickael Ohanna, Alexandrine Carminati, Ilona Berestjuk, Frederic Larbret, David Gilot, Georges Vassaux, Jean‐Christophe Marine, Marcel Deckert, Bernard Mari, Sophie Tartare‐Deckert

Subjects: Get full text

Pulmonary fibrosis complicated by lung cancer: bibliometric analysis from 2004 to 2024 - research status, trends and future directions by Boyang Li, Fan Wu, Xinlai Ma, Weishan Yuan, Jiaqing Li, Wei Zhang, Xue Liu

Subjects: Get full text

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report by María Espinosa Bosch, Rocío Asensi Diez, Sara García Agudo, Ana Clopes Estela

Subjects: Get full text

Prevention and Treatment of Peritoneal Dialysis-Associated Fibrosis with Intraperitoneal Anti-Fibrotic Therapy in Experimental Peritoneal Fibrosis by Chiao-Yin Sun, Yu-Ting Hsieh, Shang-Chieh Lu, Chi-Ying F. Huang

Subjects: Get full text

Analysis of treatment efficacy, tolerability, and survival of patients receiving antifibrotic therapy for progressive nonidiopathic pulmonary fibrosis by Nesrin Ocal, Aykut Cilli, Nesrin Mogulkoc, Funda Coskun, Ahmet Ursavas, Ismail Hanta, Berna Akinci Ozyurek, Kerem Ensarioglu, Alper Ezircan, Esra Yuksel, Beste Arikan, Fatih Uzer, Tugce Sahin Ozdemirel, Salim Misirci, Pelin Pinar Deniz, Ilknur Basyigit, Ozlem Ozdemir Kumbasar

Subjects: Get full text

Perioperative Anti-Fibrotic Treatment Prevents Acute Exacerbation of Idiopathic Pulmonary Fibrosis After Lung Cancer Surgery by Stefano Bongiolatti, Alberto Salvicchi, Elisabetta Rosi, Elena Bargagli, Giovanni Mugnaini, Alessandro Gonfiotti, Federico Lavorini, Paolo Spagnolo, Andrea Dell’Amore, Federico Rea, Luca Voltolini

Subjects: Get full text

Nintedanib regulates miR-23b-3p/TGFBR2 axis and competitively binds to TGFBR2 protein, inhibiting EMT process in human pterygium cells by Ke-Ke Zhang, Meng Li, Yan-Hong Liao, Xiao-Tian Liu, Yong-Bo Bao, Yan Gong

Subjects: Get full text

Alveolar and interstitial disease in chronic smoker presenting as combined pulmonary fibrosis with emphysema: Double trouble! by Shital Patil, Gajanan Gondhali

Subjects: Get full text

Nintedanib alleviates hyperoxia-induced lung injury via targeting NF-κB signalling pathway in rat model of bronchopulmonary dysplasia by Rui Hao, Yuping Li, Junhui Li, Zirui Guo, Zhi Yang, Wei Lu

Subjects: Get full text

Ways to improve the diagnosis and treatment of interstitial lung disease associated with systemic sclerosis in the Siberian Federal District (materials of the advisory board of rhe... by L. I. Alekseeva, S. A. Terpigorev, E. V. Zonova, L. M. Kudelya, N. M. Babadaeva, A. V. Teteneva, A. A. Kondrashov, D. N. Orlov, T. V. Raskina, O. N. Anoshenkova, Yu. P. Chasovskikh, T. V. Kropotina, A. B. Opongosheva, N. V. Yudina, N. G. Ganyukova

Subjects: Get full text

A clinical case of idiopathic pulmonary fibrosis against the background of comorbid pathology by A. V. Teteneva, V. V. Kalyuzhin, G. M. Chernyavskaya, I. D. Bespalova, G. E. Chernogoryuk, V. D. Zavadovskaya, T. V. Zhogina, E. A. Ustyuzhanina, E. V. Kuzin, I. A. Varfolomeeva, O. V. Sedlyar, E. A. Medikova, Yu. I. Koshchavtseva, K. V. Potapov, A. I. Karzilov, Ya. V. Porovsky, M. M. Solovev

Subjects: Get full text

Quantitative micro-CT-derived biomarkers elucidate age-related lung fibrosis in elder mice by Davide Buseghin, Andrea Grandi, Erica Ferrini, Gino Villetti, Roberta Ciccimarra, Nicola Sverzellati, Andrea Aliverti, Francesca Pennati, Franco Fabio Stellari

Subjects: Get full text

Successful Tepotinib Treatment in MET Exon 14 Skipping Mutation‐Positive Lung Adenocarcinoma With Idiopathic Pulmonary Fibrosis Through Nintedanib Combination by Yoshiki Kato, Takunori Ogawa, Kimiya Sato, Akira Matsukida, Akihiko Kawana, Ryosuke Nagaoka, Kotoba Esaki, Yoshifumi Kimizuka

Subjects: Get full text

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese... by Tao Wang, Zhiwei Cui, Yingyong Ou, Siyu Lou, Huayou Chen, Chengyu Zhu, Linmei Zhou, Fan Zou

Subjects: Get full text

Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach by Keting Li, Wenshu Hu, Yingjie Wang, Wenxing Chen, Hongmei Wen, Jian Liu, Wei Li, Bo Wang

Subjects: Get full text